CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.91 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹3.89 Cr |
What is the latest Contingent Liabilities ratio of CONCORD BIOTECH ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.91 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹3.89 Cr |
How is Contingent Liabilities of CONCORD BIOTECH Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.91 Cr | -72.67 | |
| Mar2024 | ₹14 Cr | 0.00 | |
| Mar2023 | ₹14 Cr | 7.43 | |
| Mar2022 | ₹13 Cr | 242.57 | |
| Mar2021 | ₹3.89 Cr | - | |
Compare Contingent Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹11,926.0 Cr | 7.7% | 8.9% | -35.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 5.9% | -0.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.5% | 8.7% | 3.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 2% | -1.6% | 25.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | -0.2% | 2.2% | 12.8% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 0.8% | 5.9% | -15.7% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 7.7% |
8.9% |
-35.1% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses